Pfizer and Astellas’ prostate cancer med Xtandi nabbed broader FDA approval, setting it up for a head-to-head fight with J&J’s Erleada.

BioMarin and Believe Limited are helping 25 high schoolers create the first-ever musical about bleeding disorders.

While support from drugmakers can be helpful for patients, sometimes support from fellow patients can be even more helpful. So Bayer is offering both.

With Johnson & Johnson's diabetes drug Invokana going up against two longtime rivals in China, the company is ramping things up.

Johnson & Johnson immunology newcomer Tremfya is looking to follow in the footsteps of its big brother Stelara.

Tally another win for Bristol-Myers Squibb’s immunotherapy combination, this time in rare colon cancers.

Lilly Oncology’s marketing chief has some key words for pharma marketers: Don’t lead with data. Put patients’ insights at the forefront instead.

Chief creative at winning agency talks creativity that leaps the old “good enough for pharma” bar.